How is 5-Amino-1MQ administered?
This describes how 5-Amino-1MQ is typically administered in clinical and research references, not a self-administration guide. The usual route is Oral, on a once or twice daily schedule, generally over 8-12 weeks. Specific dosing is individual and beyond general information, and human evidence for 5-Amino-1MQ is limited.
Administration at a glance (reference data)
- Route: Oral
- Schedule: Once or twice daily
- Cycle length: 8-12 weeks
- Half-life: ~6-8 hours
References
- Selective inhibitors of NNMT in obesity-related metabolic disease — Neelakantan H et al., Biochem Pharmacol, 2018
- Nicotinamide N-methyltransferase (NNMT): a novel therapeutic target for metabolic syndrome — Sun WD et al., Frontiers in Pharmacology, 2024
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on 5-Amino-1MQ
Last updated 2026-06-15.